Sudden Deafness
Conditions
Interventions
Experimental group:(1) Tympanical injection of dexamethasone 10mg/ml 0.5ml/ ear + oral nutrition of nerve (mecobalamine) and circulation improvement (Ginkgo biloba extract) drug + acupuncture of audit
control group:Tympanic injection of dexamethasone 10mg/ml 0.5ml/ ear + oral neurotrophic (mecobalamine) and circulatory improvement (Ginkgo biloba extract) drugs, once every 3 days, a total of 5 times
Sponsors
Wangjing Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients are between 18 and 60 years of age and of any gender. The course of the disease is within 2 weeks of onset, without relevant medical treatment. Consistent with diagnosis of sudden deafness (hearing loss = 30 dB at least 3 consecutive frequencies)
Exclusion criteria
Exclusion criteria: (1) Hormone contraindications. (2) Pregnancy, diabetes, hypertension patients. (3) Patients with Meniere's disease, middle ear disease, large vestibular duct syndrome, acoustic neuroma and other diseases. (4) suffering from epilepsy, schizophrenia and other neurological and mental diseases. (5) Those judged by the researcher to be unable to complete the experiment. (6) Full frequency hearing loss, less than 70db
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pure tone audiometry;Tinnitus score;Baseline data;Disease recovery time/rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hearing improvement at impaired frequencies; | — |
Countries
China
Contacts
Public ContactZhonghaiXin
Wangjing Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed